Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | CCR1 | P32246 | 3/20 | 0.39 |
| ▸ | CCR8 | P51685 | 3/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | CCR5 | P51681 | 2/20 | 0.38 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.35 |
| ▸ | COPS5 | Q92905 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | COMT | P21964 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22373940 | 0.88 | CCR1 (0.41) | L3MBTL1NPC1HSP90AA1CCR1CCR8 | |
| SCHEMBL16919861 | 0.79 | ALDH1A1 (0.42) | L3MBTL1NPC1HSP90AA1CCR1CCR8 | |
| SCHEMBL17033990 | 0.79 | AHR (0.47) | NPC1CYP1A2CYP2A6MEN1KMT2A | |
| SCHEMBL22373883 | 0.78 | KDM4E (0.46) | L3MBTL1NPC1HSP90AA1CCR1CCR8 | |
| SCHEMBL13509561 | 0.76 | NPC1 (0.41) | L3MBTL1NPC1HSP90AA1CCR1CCR8 | |
| SCHEMBL6925972 | 0.74 | KDM4E (0.48) | L3MBTL1NPC1HSP90AA1CCR1CCR8 | |
| SCHEMBL21026835 | 0.74 | COMT (0.42) | L3MBTL1NPC1HSP90AA1CCR1CCR8 | |
| SCHEMBL24623618 | 0.74 | MEN1 (0.38) | L3MBTL1NPC1HSP90AA1CCR1CCR8 | |
| SCHEMBL22373873 | 0.74 | NFATC1 (0.35) | NPC1CYP1A2CYP2A6KMT2AKDM4E | |
| SCHEMBL19721275 | 0.74 | CCR1 (0.54) | L3MBTL1NPC1HSP90AA1CCR1CCR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230389413-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2023-11-30 | — | — | US | disclosed |
| US-20230389413-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2023-11-30 | — | — | US | disclosed |
| US-11758807-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION | 2023-09-12 | — | — | US | disclosed |
| US-11758807-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION | 2023-09-12 | — | — | US | disclosed |
| US-20200274081-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2020-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230389413-A1 | Organic Electroluminescent Materials and Devices | GLRA3, ESRRG, GLRA1 | L3MBTL1 1754/4885NPC1 4127/4885HSP90AA1 4213/4885 |
| US-20200274081-A1 | Organic Electroluminescent Materials and Devices | GLRA3, ESRRG, GLRA1 | L3MBTL1 1754/4885NPC1 4127/4885HSP90AA1 4213/4885 |
| US-11758807-B2 | Organic electroluminescent materials and devices | GLRA3, ESRRG, GLRA1 | L3MBTL1 1754/4885NPC1 4127/4885HSP90AA1 4213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.